Informace o publikaci

Determination of pCrkL level in chronic myeloid leukaemia cells using flow cytometry

Autoři

ŠIMARA Pavel STEJSKAL Stanislav PETERKOVÁ Martina KRONTORÁD KOUTNÁ Irena RÁČIL Zdeněk MAYER Jiří

Rok publikování 2010
Druh Článek ve sborníku
Konference Advances in Molecular and Cancer Biology, 2010
Fakulta / Pracoviště MU

Fakulta informatiky

Citace
Obor Genetika a molekulární biologie
Klíčová slova CML; imatinib; CD34+; pCrkL; flow cytometry
Popis Imatinib is a tyrosine kinase inhibitor nowadays used as a first line therapy for newly diagnosed chronic myeloid leukaemia (CML) patients. However, some of the patients relapse after initially good response. Therefore, reliable methods for predicting of the imatinib treatment response are sought. In our research we determine the level of phosphorylated CrkL protein, known as a substrate of Bcr-Abl, by flow cytometry. Its potential predictive value as a marker of imatinib treatment response will be assessed in the monuclear cells or CD34+ cells of peripheral blood samples of new CML patients.
Související projekty:

Používáte starou verzi internetového prohlížeče. Doporučujeme aktualizovat Váš prohlížeč na nejnovější verzi.

Další info